Definition: Vasculitis is inflammation of blood vessels, leading to vessel wall damage, narrowing, or occlusion, which can compromise blood flow and result in organ damage.
Classification:
Large vessel vasculitis: Affects large arteries (e.g., giant cell arteritis, Takayasu arteritis).
Small vessel vasculitis: Affects small arteries, capillaries, and venules (e.g., granulomatosis with polyangiitis, microscopic polyangiitis, Henoch-Schönlein purpura).
Etiology:
Idiopathic in most cases, but may be secondary to infections, autoimmune disorders, medications, or malignancies.
Clinical Features
General Symptoms:
Systemic symptoms like fever, fatigue, weight loss, and muscle pain.
Organ-specific symptoms depend on the type of vasculitis and affected vessels.
Autoantibodies: ANCA (for GPA and MPA), elevated IgA (for HSP).
Basic labs may show anemia of chronic disease, leukocytosis, and elevated creatinine in renal involvement.
Imaging:
Angiography: Useful for detecting vessel stenosis or aneurysms in medium and large vessel vasculitis.
CT or MRI: To evaluate structural abnormalities in vessels.
Biopsy:
The gold standard for diagnosing vasculitis, particularly small vessel vasculitis.
Treatment
Corticosteroids:
High-dose corticosteroids are first-line treatment for most vasculitis cases.
Tapering regimen required to prevent relapse after symptom control.
Immunosuppressive Agents:
Cyclophosphamide, methotrexate, or azathioprine for severe or refractory cases.
Rituximab: Used in ANCA-associated vasculitis (GPA, MPA).
Biologics and Special Therapies:
Tocilizumab: Used for giant cell arteritis.
IVIG: Administered in Kawasaki disease to prevent coronary artery aneurysms.
Essential Points
Vasculitis is classified based on the size of the affected vessels: large, medium, or small.
Diagnosis involves clinical features, laboratory testing (e.g., ANCA, ESR), imaging, and biopsy when needed.
Early treatment with corticosteroids and immunosuppressants is essential to prevent irreversible organ damage.
Prompt recognition and management of conditions like giant cell arteritis and Kawasaki disease are critical to avoid severe complications such as blindness or coronary aneurysms.